[1] Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, Dickerson BC, Vandenberghe R, Ahmed S, Bak TH, Boeve BF, Butler C, Cappa SF, Ceccaldi M, de Souza LC, Dubois B, Felician O, Galasko D, Graff-Radford J, Graff-Radford NR, Hof PR, Krolak-Salmon P, Lehmann M, Magnin E, Mendez MF, Nestor PJ, Onyike CU, Pelak VS, Pijnenburg Y, Primativo S, Rossor MN, Ryan NS, Scheltens P, Shakespeare TJ, Suárez González A, Tang-Wai DF, Yong KXX, Carrillo M, Fox NC; Alzheimer's Association ISTAART Atypical Alzheimer's Disease and Associated Syndromes Professional Interest Area. Consensus classification of posterior cortical atrophy[J]. Alzheimers Dement, 2017, 13:870-884. [2] Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy[J]. Arch Neurol, 1988, 45:789-793. [3] Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL. Advancing research diagnostic criteria for Alzheimer's disease:the IWG-2 criteria[J]. Lancet Neurol, 2014, 13:614-629. posterior [4] Holden SK, Bettcher BM, Pelak VS. Update on cortical atrophy[J]. Curr Opin Neurol, 2020, 33:68-73. [5] Folstein MF, Folstein SE, McHugh PR. "Mini-mental state":a practical method for grading the cognitive state of patients for the clinician[J]. J Psychiatr Res, 1975, 12:189-198. [6] Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA:a brief screening tool for mild cognitive impairment[J]. J Am Geriatr Soc, 2005, 53:695-699. test-revised: [7] Benedict RH. Brief visuospatial memory professional manual[M]. Florida:Psychological Assessment Resources, 1997. [8] Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins verbal learning test-revised:normative data and analysis of inter-form and test-retest reliability[J]. Clin Neuropsychol, 1998, 12:43-55. Lieh-Mak F. Semantic verbal fluency [9] Chen YL, Chen YH, deficit as a familial trait marker in schizophrenia[J]. Psychiatry Res, 2000, 95:133-148. [10] Beck LH, Bransome ED Jr, Mirsky AF, Rosvold HE, Sarason I. A continuous performance test of brain damage[J]. J Consult Psychol, 1956, 20:343-350. [11] Daly JM, Xu Y, Crockett SD, Schmidt ME, Kim P, Levy BT. Clock-drawing test as a screening tool for cognitive impairment associated with fecal immunochemical test collection errors[J]. Ann Fam Med, 2022, 20:452-459. [12] Hong X, Zhang ZX, Wu LY, Shi LL, Zhao XH, Wei J. Validity of complex figure test in differentiation of Alzheimer's disease from non-dementia[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2013, 35:348-352.[洪霞, 张振馨, 武力勇, 史丽丽, 赵晓晖, 魏镜. 复杂图形测验对区分阿尔茨海默病与非痴呆的诊断效度[J]. 中国医学科学院学报, 2013, 35:348-352.] [13] Sun XY, Li YX, Yu CQ, Li LM. Reliability and validity of depression scales of Chinese version:a systematic review[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2017, 38:110-116.[孙晓艳, 李怡雪, 余灿清, 李立明. 中文版抑郁量表信效度研究的系统综述[J]. 中华流行病学杂志, 2017, 38:110-116.] and [14] He XY, Li CB, Qian J, Cui HS, Wu WY. Reliability validity of a generalized anxiety disorder scale in general hospital outpatients[J]. Shanghai Jing Shen Yi Xue, 2010, 22:200-203.[何筱衍, 李春波, 钱洁, 崔海松, 吴文源. 广泛性焦虑量表在综合性医院的信度和效度研究[J]. 上海精神医学, 2010, 22:200-203.] people:self- [15] Lawton MP, Brody EM. Assessment of older maintaining and instrumental activities of daily living[J]. Gerontologist, 1969, 9:179-186. [16] Koedam EL, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YA. Early-versus late-onset Alzheimer's disease:more than age alone[J]. J Alzheimers Dis, 2010, 19:1401-1408. CL, Julien CL, Thompson JC, Davidson [17] Snowden JS, Stopford Y, Gibbons L, Pritchard A, Lendon CL, Richardson AM, Varma A, Neary D, Mann D. Cognitive phenotypes in Alzheimer's disease and genetic risk[J]. Cortex, 2007, 43:835-845. DA, [18] Singh TD, Josephs KA, Machulda MM, Drubach Apostolova LG, Lowe VJ, Whitwell JL. Clinical, FDG and amyloid PET imaging in posterior cortical atrophy[J]. J Neurol, 2015, 262:1483-1492. BF, Dickson DW, [19] Tang-Wai DF, Graff-Radford NR, Boeve Parisi JE, Crook R, Caselli RJ, Knopman DS, Petersen RC. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy[J]. Neurology, 2004, 63:1168-1174. M, [20] Maia da Silva MN, Millington RS, Bridge H, James-Galton Plant GT. Visual dysfunction in posterior cortical atrophy[J]. Front Neurol, 2017, 8:389. primates[J]. [21] Trevarthen CB. Two mechanisms of vision in Psychol Forsch, 1968, 31:299-348. [22] Lu KH, Jeong JY, Wen H, Liu Z. Spontaneous activity in the visual cortex is organized by visual streams[J]. Hum Brain Mapp, 2017, 38:4613-4630. [23] Liu Y, Cui Y, Liu L, Bai YY, Jing DL, Wu LY. Study on posterior cortical atrophy visual disorders[J]. Nao Yu Shen Jing Ji Bing Za Zhi, 2019, 27:574-576.[刘阳, 崔玥, 刘琳, 白艳艳, 靖冬来, 武力勇. 后部皮质萎缩视觉障碍研究[J]. 脑与神经疾病杂志, 2019, 27:574-576.] [24] Jia J, Wang J, Sun Y, Ma CB, Liu AG, Yan XK. A review of studies on two parallel visual streams in cortex:the dorsal and ventral visual pathways[J]. Zhonghua Yan Shi Guang Xue Yu Shi Jue Ke Xue Za Zhi, 2022, 24:316-320.[贾静, 王觉, 孙燕, 马重兵, 刘安国, 严兴科. 视皮层背侧、腹侧流视觉通路的研究进展[J]. 中华眼视光学与视觉科学杂志, 2022, 24:316-320.] [25] McMonagle P, Deering F, Berliner Y, Kertesz A. The cognitive profile of posterior cortical atrophy[J]. Neurology, 2006, 66:331-338. [26] de Best PB, Raz N, Guy N, Ben-Hur T, Dumoulin SO, Pertzov Y, Levin N. Role of population receptive field size in complex visual dysfunctions:a posterior cortical atrophy model[J]. JAMA Neurol, 2019, 76:1391-1396. [27] Kas A, de Souza LC, Samri D, Bartolomeo P, Lacomblez L, Kalafat M, Migliaccio R, Thiebaut de Schotten M, Cohen L, Dubois B, Habert MO, Sarazin M. Neural correlates of cognitive impairment in posterior cortical atrophy[J]. Brain, 2011, 134(Pt 5):1464-1478. [28] Firth NC, Primativo S, Marinescu RV, Shakespeare TJ, Suarez-Gonzalez A, Lehmann M, Carton A, Ocal D, Pavisic I, Paterson RW, Slattery CF, Foulkes AJM, Ridha BH, Gil-Néciga E, Oxtoby NP, Young AL, Modat M, Cardoso MJ, Ourselin S, Ryan NS, Miller BL, Rabinovici GD, Warrington EK, Rossor MN, Fox NC, Warren JD, Alexander DC, Schott JM, Yong KXX, Crutch SJ. Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy[J]. Brain, 2019, 142:2082-2095. [29] Mitchell SB, Lucente D, Larvie M, Cobos MI, Frosch M, Dickerson BC. A 63-year-old man with progressive visual symptoms[J]. JAMA Neurol, 2017, 74:114-118. [30] Crutch SJ, Lehmann M, Warren JD, Rohrer JD. The language profile of posterior cortical atrophy[J]. J Neurol Neurosurg Psychiatry, 2013, 84:460-466. M, Thompson S, Kipps C, [31] Ahmed S, Baker I, Husain Hornberger M, Hodges JR, Butler CR. Memory impairment at initial clinical presentation in posterior cortical atrophy[J]. J Alzheimers Dis, 2016, 52:1245-1250. [32] Putcha D, McGinnis SM, Brickhouse M, Wong B, Sherman JC, Dickerson BC. Executive dysfunction contributes to verbal encoding and retrieval deficits in posterior cortical atrophy[J]. Cortex, 2018, 106:36-46. [33] Vogel JW, Young AL, Oxtoby NP, Smith R, Ossenkoppele R, Strandberg OT, La Joie R, Aksman LM, Grothe MJ, Iturria-Medina Y, Pontecorvo MJ, Devous MD, Rabinovici GD, Alexander DC, Lyoo CH, Evans AC, Hansson O; Alzheimer's Disease Neuroimaging Initiative. Four distinct trajectories of tau deposition identified in Alzheimer's disease[J]. Nat Med, 2021, 27:871-881. H, Petersen RC, Chételat G, Holtzman [34] Knopman DS, Amieva DM, Hyman BT, Nixon RA, Jones DT. Alzheimer disease[J]. Nat Rev Dis Primers, 2021, 7:33. [35] Katsumi Y, Putcha D, Eckbo R, Wong B, Quimby M, McGinnis S, Touroutoglou A, Dickerson BC. Anterior dorsal attention network tau drives visual attention deficits in posterior cortical atrophy[J]. Brain, 2023, 146:295-306. [36] Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X. Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention[J]. Ageing Res Rev, 2022, 74:101544. [37] Seguin J, Formaglio M, Perret-Liaudet A, Quadrio I, Tholance Y, Rouaud O, Thomas-Anterion C, Croisile B, Mollion H, Moreaud O, Salzmann M, Dorey A, Bataillard M, Coste MH, Vighetto A, Krolak-Salmon P. CSF biomarkers in posterior cortical atrophy[J]. Neurology, 2011, 76:1782-1788. [38] Montembeault M, Brambati SM, Lamari F, Michon A, Samri D, Epelbaum S, Lacomblez L, Lehéricy S, Habert MO, Dubois B, Kas A, Migliaccio R. Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers[J]. Neuroimage Clin, 2018, 20:1018-1025. [39] Paterson RW, Toombs J, Slattery CF, Nicholas JM, Andreasson U, Magdalinou NK, Blennow K, Warren JD, Mummery CJ, Rossor MN, Lunn MP, Crutch SJ, Fox NC, Zetterberg H, Schott JM. Dissecting IWG-2 typical and atypical Alzheimer's disease:insights from cerebrospinal fluid analysis[J]. J Neurol, 2015, 262:2722-2730. [40] Schott JM, Crutch SJ, Carrasquillo MM, Uphill J, Shakespeare TJ, Ryan NS, Yong KX, Lehmann M, Ertekin-Taner N, Graff-Radford NR, Boeve BF, Murray ME, Khan QU, Petersen RC, Dickson DW, Knopman DS, Rabinovici GD, Miller BL, González AS, Gil-Néciga E, Snowden JS, Harris J, Pickering-Brown SM, Louwersheimer E, van der Flier WM, Scheltens P, Pijnenburg YA, Galasko D, Sarazin M, Dubois B, Magnin E, Galimberti D, Scarpini E, Cappa SF, Hodges JR, Halliday GM, Bartley L, Carrillo MC, Bras JT, Hardy J, Rossor MN, Collinge J, Fox NC, Mead S. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease[J]. Alzheimers Dement, 2016, 12:862-871. [41] Ikeda M, Kodaira S, Kasahara H, Takai E, Nagashima K, Fujita Y, Makioka K, Hirayanagi K, Furuta N, Furuta M, Sanada E, Kobayashi A, Harigaya Y, Nagamine S, Hattori N, Tashiro Y, Kishi K, Shimada H, Suto T, Tanaka H, Sakai Y, Yamazaki T, Tanaka Y, Aihara Y, Amari M, Yamaguchi H, Okamoto K, Takatama M, Ishii K, Higuchi T, Tsushima Y, Ikeda Y. Cerebral microbleeds, cerebrospinal fluid, and neuroimaging markers in clinical subtypes of Alzheimer's disease[J]. Front Neurol, 2021, 12:543866. [42] Wang JQ. Clinical and neuroimaging differences between posterior cortical atrophy and typical amnestic Alzheimer's disease patients at an early disease stage[D]. Zhejiang:Zhejiang University, 2016.[王建琴. 后部皮质萎缩症和典型遗忘型阿尔茨海默病的临床特征学比较研究[D]. 浙江:浙江大学, 2016.] [43] Mendez MF, Ghajarania M, Perryman KM. Posterior cortical atrophy:clinical characteristics and differences compared to Alzheimer's disease[J]. Dement Geriatr Cogn Disord, 2002, 14:33-40. [44] Chan LT, Lynch W, De May M, Horton JC, Miller BL, Rabinovici GD. Prodromal posterior cortical atrophy:clinical, neuropsychological, and radiological correlation[J]. Neurocase, 2015, 21:44-55. [45] Cordano C, Alessandria G, Leonardi A, Cellerino M, Nourbakhsh B, Nobili F, Bandini F. Homonymous hemianopia as the first sign of posterior cortical atrophy[J]. J Neurol Sci, 2017, 373:38-40. [46] Millington RS, James-Galton M, Maia Da Silva MN, Plant GT, Bridge H. Lateralized occipital degeneration in posterior cortical atrophy predicts visual field deficits[J]. Neuroimage Clin, 2017, 14:242-249. [47] Kim J, Jeong M, Stiles WR, Choi HS. Neuroimaging modalities in Alzheimer's disease:diagnosis and clinical features[J]. Int J Mol Sci, 2022, 23:6079. [48] Kujovic M, Malikovic A, Jochum S, Margittai Z, Lange-Asschenfeldt C, Supprian T. Longitudinal progression of posterior cortical atrophy over 11 years:relationship between lesion topology and clinical deficits[J]. J Clin Exp Neuropsychol, 2019, 41:875-880. [49] DE Brito MH, Zampieri PF, Coutinho AM, Brucki SMD. Brain[18F] FDG PET-CT imaging in posterior cortical atrophy[J]. Arq Neuropsiquiatr, 2019, 77:752-753. [50] Lin HM, Lu JY, Chen KL, Xiao JF, Ju ZZ, Guo QH, Wu P, Zuo CT. Characteristics of brain glucose metabolism and its correlation with cognitive function in patients with posterior cortical atrophy[J]. Zhongguo Lin Chuang Shen Jing Ke Xue, 2022, 30:414-420.[林华媚, 鲁佳荧, 陈科良, 肖见飞, 琚紫昭, 郭起浩, 吴平, 左传涛. 后部皮质萎缩患者脑部葡萄糖代谢特征及其与认知功能的相关性分析[J]. 中国临床神经科学, 2022, 30:414-420.] [51] Liu S, Yue W, Lu H, Song DJ, Fan XH, Cai L, Wang Y, Liu J, Ji Y. Diagnostic value of 18F-FDG PET and 11C-PIB PET on early stage posterior cortical atrophy[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2015, 15:623-630.[刘帅, 岳伟, 卢昊, 宋冬晶, 范小红, 蔡莉, 王颖, 柳净, 纪勇. 18F-FDG PET和11C-PIB PET显像对后部皮质萎缩的早期诊断价值[J]. 中国现代神经疾病杂志, 2015, 15:623-630.] [52] Wang HY, Ma LM, Sun YJ, Zhao J, Sun RH, Li G, Zhang JW. Clinical characteristics analysis of posterior cortical atrophy in 5 cases[J]. Zhonghua Yi Xue Za Zhi, 2019, 99:2859-2861.[王华园, 马丽敏, 孙雅静, 赵静, 孙瑞华, 李改, 张杰文. 后部皮质萎缩五例临床特点分析[J]. 中华医学杂志, 2019, 99:2859-2861.] [53] Yuan Q. Clinical and imaging features of posterior cortical atrophy[J]. Zhong Feng Yu Shen Jing Ji Bing Za Zhi, 2021, 38:46-48.[袁泉. 后部皮质萎缩的临床及影像学特点[J]. 中风与神经疾病杂志, 2021, 38:46-48.] [54] Ridha BH, Crutch S, Cutler D, Frost C, Knight W, Barker S, Epie N, Warrington EK, Kukkastenvehmas R, Douglas J, Rossor MN. A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's disease:DONIPAD study[J]. Alzheimers Res Ther, 2018, 10:44. [55] Shakespeare TJ, Yong KX, Foxe D, Hodges J, Crutch SJ. Pronounced impairment of everyday skills and self-care in posterior cortical atrophy[J]. J Alzheimers Dis, 2015, 43:381-384. [56] Suárez-González A, Henley SM, Walton J, Crutch SJ. Posterior cortical atrophy:an atypical variant of Alzheimer disease[J]. Psychiatr Clin North Am, 2015, 38:211-220. [57] Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, Rabinovici GD, Schott JM, Jones DT, Murray ME. New insights into atypical Alzheimer's disease in the era of biomarkers[J]. Lancet Neurol, 2021, 20:222-234. |